Red Biotechnology Market, By Product Type (Biopharmaceuticals, Biosimilars, Gene Therapy, Tissue Engineering, Cell Therapy), By Application (Drug Discovery & Development, Animal Biotechnology, Environmental Biotechnology, Medical Biotechnology, Industrial Biotechnology, Agricultural Biotechnology, Others), By End User (Pharmaceutical & Biopharmaceutical Companies, Research Institutes, Biotechnology Industry, Hospitals & Diagnostic Centers, Academic Institutions), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
Red biotechnology, also known as medical biotechnology, is a subsector of biotechnology that focuses on medical and healthcare applications. It involves the use of biotechnology techniques to develop new drugs, therapies, and medical technologies for the treatment and prevention of diseases. Moreover, Red biotechnology is used in the development of diagnostic tools, such as genetic tests, that can be used to detect diseases at an early stage. Red biotechnology is also used in stem cell research, which has the potential to revolutionize the treatment of a wide range of diseases and conditions, from cancer to spinal cord injuries. Furthermore, Red biotechnology plays a crucial role in the discovery and development of new drugs. This includes the use of genetic engineering to create novel therapies, as well as the development of personalized medicine based on an individual's genetic profile. Red biotechnology is used in gene therapy, a technique that uses genes to treat or prevent disease. This can involve replacing a faulty gene, or introducing a new gene into the body to help fight disease.
Market Dynamics:
Global red biotechnology market growth is driven by several factors like increasing global healthcare needs due to aging populations, rising chronic diseases, and pandemics. Advances in genomics, personalized medicine, and gene therapies are also key drivers for the market growth. Government investments, regulatory support, and growing private sector interest contribute to the growth of global red biotechnology that aims to develop innovative medical treatments and therapies. However, high costs associated with biologics drug development is expected to restrain the market growth.
Key features of the study:
- This report provides in-depth analysis of the global red biotechnology market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global red biotechnology market based on the following parameters–company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Amgen Inc., Gilead Sciences, Inc., Biogen, Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Johnson & Johnson Services, Inc., Sanofi, Merck & Co. Inc., AbbVie Inc., GSK plc., AstraZeneca, Eli Lilly and Company, Novo Nordisk A/S, Bayer AG, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH and Astellas Pharma Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global red biotechnology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global red biotechnology market
- By Product Type
- Biopharmaceuticals
- Biosimilars
- Gene Therapy
- Tissue Engineering
- Cell Therapy
- By Application
- Drug Discovery & Development
- Animal Biotechnology
- Environmental Biotechnology
- Medical Biotechnology
- Industrial Biotechnology
- Agricultural Biotechnology
- Others
- By End User
- Pharmaceutical & Biopharmaceutical Companies
- Research Institutes
- Biotechnology Industry
- Hospitals & Diagnostic Centers
- Academic Institutions
- Top companies in Global Red Biotechnology Market
- Amgen Inc.
- Gilead Sciences, Inc.
- Biogen
- Pfizer Inc.
- Novartis AG,
- F.Hoffmann-La Roche
- Johnson & Johnson Services, Inc.
- Sanofi
- Merck & Co. Inc.
- AbbVie Inc.
- GSK plc.
- AstraZeneca
- Eli Lilly and Company
- Novo Nordisk A/S
- Bayer AG
- Bristol-Myers Squibb Company
- Teva Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Company Limited
- Boehringer Ingelheim International GmbH
- Astellas Pharma Inc
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet , By End User
- Market Snippet , By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing prevalence of chronic diseases
- Pricing pressures on biologics
- Biotech applications in agriculture
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- 4. Global Red Biotechnology Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
- 5. Global Red Biotechnology Market, By Product Type, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 – 2030
- Segment Trends
- Biopharmaceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Biosimilars
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Tissue Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- 6. Global Red Biotechnology Market, By Application, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 – 2030
- Segment Trends
- Drug Discovery & Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Animal Biotechnology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Environmental Biotechnology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Medical Biotechnology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Industrial Biotechnology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Agricultural Biotechnology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- 7. Global Red Biotechnology Market, By End User, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 – 2030
- Segment Trends
- Pharmaceutical & Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Biotechnology Industry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Hospitals & Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Academic Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- 8. Global Red Biotechnology Market, By Region, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
- South Africa
- North Africa
- Central Africa
- 9. Competitive Landscape
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Gilead Sciences, Inc.
- Biogen
- Pfizer Inc.
- Novartis AG
- F.Hoffmann-La Roche
- Johnson & Johnson Services, Inc.
- Sanofi
- Merck & Co. Inc.
- AbbVie Inc.
- GSK plc.
- AstraZeneca
- Eli Lilly and Company
- Novo Nordisk A/S
- Bayer AG
- Bristol-Myers Squibb Company
- Teva Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Company Limited
- Boehringer Ingelheim International GmbH
- Astellas Pharma Inc.
- Analyst Views
- 10. Section
- Research Methodology
- About us
- *Browse 25 market data tables and 39 figures on “Global Red Biotechnology Market” - Global forecast to 2030
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook